Strongbridge Biopharma Plc (SBBP) Return on Investment ROI from the second quarter of 2021 to second quarter of 2020 and for the year 2021, average high and low, overall ranking from Jun 30 2021 to Jun 30 2020 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Strongbridge Biopharma plc  (NASDAQ: SBBP)


Strongbridge Biopharma Plc's ROI from its second quarter of 2021 to the second quarter of 2020 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Strongbridge Biopharma Plc's ROI in the second quarter of 2021?
Strongbridge Biopharma Plc recorded a cumulative net loss of $-40 million during 12 months ending in the second quarter of 2021, resulting in a negative return on investment (ROI) of -43.81%.

Within the Healthcare sector 640 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2021 from 0 to 4412.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter
Y / Y Investment Change TTM 3.44 % -4.69 % -18.83 % -29.82 % -32.82 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 76 89 101 101 81
Return On Investment (TTM) -43.81 % -47.58 % -50.07 % -47.7 % -59.51 %
SBBP's Overall Ranking # 4412 # 0 # 0 # 0 # 0
Seq. Investment Change TTM -1.31 % 3.17 % 1.98 % -0.38 % -9.07 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -40 -44 -45 -42 -53

SBBP Company Profile >> Back to SBBP Roi Comparisons >> See Annual SBBP Return On Investment



Return On Investment SBBP's Ranking
Within: No.
Industry # 267
Sector # 641
Overall # 4412

Return On Investment Statistics
High Average Low
34.65 %
-51.41 %
-118.45 %
(Sep 30 2019)   (Dec 31 2017)







Financial Statements
Strongbridge Biopharma Plc's II. Quarter Investments $ 76 Millions SBBP's Balance sheet
Strongbridge Biopharma Plc's II. Quarter Income $ -13 Millions Quarterly SBBP's Income Statement
SBBP's Income by Division See SBBP's Income by Division


SBBP Annual Return On Investment (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016
Total Investments in Millions 101 94 153 91 122
Y / Y Investment Growth 7.46 % -38.86 % 67.35 % -25 % 30.27 %
Net Income in Millions -45 -49 32 -113 -49
Y / Y Net Income Growth - - - - -
Annual Return On Investment -44.83 % -52.85 % 20.81 % -124.1 % -39.96 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
SBBP's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for SBBP's Competitors
Subscribers only: Roi for Strongbridge Biopharma Plc's Suppliers
Subscribers only: Return On Investment for SBBP's Customers

Other Ratios
SBBP's Roa SBBP's Inventory Turnover Ratio SBBP's Growth Rates SBBP's Dividend Statistics
SBBP's Profitability Ratios SBBP's Asset Turnover Ratio SBBP's Dividend Growth
SBBP's Roe SBBP's Valuation Ratios SBBP's Financial Strength Ratios SBBP's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2021, within Healthcare Sector ROI

Date modified: 2026-09-08T15:10:20+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.